Han Kun Law Offices
  January 4, 2024 - Mainland China

Anatomy of Licensing Deals from China Regulatory Perspective
  by Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that's never easy. Along the journey, an individual may stride resolutely, yet with companionship, two can traverse faster and farther. Therefore, pharmaceutical companies have been frequently collaborating in the research and development of drugs and medical devices to leverage each other's resources, share risks, explore regional markets, achieve profit maximization, or promote mutually beneficial effects in strategic partnerships. Meanwhile, licensing transactions are commonly used for the implementation of collaborative projects in the field of drugs and medical devices (including medical aesthetics).




Read full article at: https://www.hankunlaw.com/upload/portal/20240109/d2a2683407baa0f3234badbae7e58e42.pdf